TuHURA BIOSCIENCES, INC./NV Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent
TuHURA BIOSCIENCES, INC./NV (HURA) reported Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent of -$1.87 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-12.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 · last filed 2017-09-27
- TuHURA BIOSCIENCES, INC./NV other comprehensive income (loss), tax, portion attributable to parent for the quarter ending 2017-03-31 was -$1.87M.
- TuHURA BIOSCIENCES, INC./NV other comprehensive income (loss), tax, portion attributable to parent for the quarter ending 2016-06-30 was $5.51M.
- TuHURA BIOSCIENCES, INC./NV other comprehensive income (loss), tax, portion attributable to parent for the quarter ending 2016-03-31 was -$1.14M.
- TuHURA BIOSCIENCES, INC./NV other comprehensive income (loss), tax, portion attributable to parent for fiscal 2016 was $100.87K.
| Period end | Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$1.87M 10-Q · filed 2017-05-12 | -$5.48M 10-Q · filed 2017-05-12 | ||
| 2016-06-30 | $5.51M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-27 | $4.37M derived: sum of 2 quarters · filed 2017-09-27 | $100.87K 10-K · filed 2017-09-27 | |
| 2016-03-31 | -$1.14M 10-Q · filed 2017-05-12 | -$5.41M 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |